BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 38085392)

  • 1. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
    Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
    Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term outcome of nephron-sparing surgery versus radical nephroureterectomy for organ-localized upper urinary tract urothelial carcinoma: a population-based study of 1969 patients.
    Qiu J; Deng R; Yu C; Gong K
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14869-14878. PubMed ID: 37598342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
    Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
    World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of preoperative body mass index on prognosis for patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
    Chen JC; Huang TH; Wei TC; Huang IS; Fan YH; Lin CC; Lin TP; Chung HJ; Lu SH; Kuo JY; Wu HHH; Chang YH; Lin ATL; Huang WJ; Huang EY
    World J Urol; 2023 Dec; 41(12):3575-3583. PubMed ID: 37924334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic outcomes of patients treated with kidney-sparing surgery or radical nephroureterectomy for upper urinary tract urothelial cancer: a population-based study.
    Ślusarczyk A; Zapała P; Zapała Ł; Rajwa P; Moschini M; Laukhtina E; Radziszewski P
    Urol Oncol; 2024 Jan; 42(1):22.e1-22.e11. PubMed ID: 37981503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.
    Sharma V; Miest TS; Juvet TS; Toussi A; Packiam V; Chamie K; Matin SF; Boorjian SA; Thompson RH; Frank I; Tollefson MK; Potretzke AM
    J Urol; 2021 Sep; 206(3):558-567. PubMed ID: 33908802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker for the oncological outcomes of radical nephroureterectomy.
    Gwak CH; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Hong B; Ahn H
    Urol Oncol; 2024 Feb; 42(2):30.e17-30.e23. PubMed ID: 38072737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy.
    Kobayashi Y; Arai H; Hamamoto Y; Yoshida K; Shimizu S; Yasuhara Y; Ichimaru N
    Clin Genitourin Cancer; 2023 Oct; 21(5):e386-e393. PubMed ID: 37244798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
    Yu TY; Wang HJ; Sung MT; Chuang YC; Chen YT; Cheng YT; Kang CH; Liu HY; Chang YL; Luo HL
    Int J Urol; 2024 Apr; 31(4):410-418. PubMed ID: 38169055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact of variant histology in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Ye J; Wang X; Liao X; Chen Z; Wang X; Zhang C; Han P; Wei Q; Bao Y
    Urol Oncol; 2024 Mar; 42(3):69.e1-69.e9. PubMed ID: 38151426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group.
    Douglawi A; Ghoreifi A; Carbonara U; Yip W; Uzzo RG; Margulis V; Ferro M; Cobelli O; Wu Z; Simone G; Mastroianni R; Rha KH; Eun DD; Reese AC; Porter JR; Derweesh I; Mehrazin R; Rosiello G; Tellini R; Jamil M; Kenigsberg A; Farrow JM; Schrock WP; Cacciamani G; Srivastava A; Bhattu AS; Mottrie A; Gonzalgo ML; Sundaram CP; Abdollah F; Minervini A; Autorino R; Djaladat H
    Clin Genitourin Cancer; 2023 Oct; 21(5):563-568. PubMed ID: 37301663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
    Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
    BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
    Huang EY; Tai MC; Chung HJ; Chang YH; Huang WJ
    Int Braz J Urol; 2023; 49(4):469-478. PubMed ID: 37267612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a novel immune and nutritional score on prognosis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.
    Liu J; Lai S; Wu P; Wang J; Wang J; Wang J; Zhang Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10893-10909. PubMed ID: 37318591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for overall survival in clinical node-positive patients with upper tract urothelial carcinoma.
    Sasahara T; Yanagisawa T; Sugaya S; Hisakane A; Sakanaka K; Hara S; Otsuka T; Takamizawa S; Yata Y; Takahashi Y; Takiguchi Y; Mori K; Tsuzuki S; Kimura S; Miki J; Kimura T
    Int J Urol; 2024 Apr; 31(4):386-393. PubMed ID: 38169105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open versus minimally invasive nephroureterectomy in octogenarians: An analysis of surgical approach trends, outcomes, and survival analysis with propensity matching.
    Trecarten S; Bhandari M; Abdelaziz A; Noel O; Liss M; Dursun F; Svatek R; Mansour AM
    Urol Oncol; 2024 Jul; 42(7):220.e9-220.e19. PubMed ID: 38631967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning.
    Liu J; Wu P; Lai S; Wang J; Hou H; Zhang Y
    BMC Cancer; 2023 Jun; 23(1):574. PubMed ID: 37349696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis.
    Cirulli GO; Corsi N; Rakic I; Stephens A; Chiarelli G; Finati M; Davis M; Tinsley S; Sood A; Buffi N; Lughezzani G; Carrieri G; Salonia A; Briganti A; Montorsi F; Rogers C; Abdollah F
    BJU Int; 2024 May; 133(5):555-563. PubMed ID: 38097533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Value of Preoperative Naples Prognostic Score in Upper Tract Urothelial Carcinoma Patients after Radical Nephroureterectomy.
    Ye J; Chen Z; Pan Y; Liao X; Wang X; Zhang C; Wang Q; Han P; Wei Q; Bao Y
    Nutr Cancer; 2024; 76(1):80-88. PubMed ID: 37941300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.